Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: An integrated device-based strategy

Journal of Endovascular Therapy

Volumn 13, Issue SUPPL. 2, 2006, Pages

  Lyden, Sean P ^a,c   Shimshak, Thomas M ^b,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Wheaton Franciscan Healthcare St Joseph's Hospital   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL; POLITEF; RAPAMYCIN;

ALGORITHM; ARTERY DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CRYOTHERAPY; DEVICE; DIRECTIONAL ATHERECTOMY; DRUG ELUTING STENT; ENDOVASCULAR THERAPY; GRAFT PATENCY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTERVENTIONAL RADIOLOGY; LASER ANGIOPLASTY; MECHANICAL STRESS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; QUALITY OF LIFE; RESTENOSIS; REVASCULARIZATION; STENT; SUPERFICIAL FEMORAL ARTERY; SYMPTOMATOLOGY; TECHNOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33244464521     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/05-1757.1     Document Type: Conference Paper

References (41)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
2. Lugmayr HF, Holzer H, Kastner M, et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology. 2002;222:37-43.
3. Wolosker N, Nakano L, Anacleto MM, et al. Primary utilization of stents in angioplasty of superficial femoral artery. Vasc Endovascular Surg. 2003;37:271-277.
4. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vase Interv Radiol. 2004;7:2-5.
5. Muradin GS, Bosch JL, Stijnen T, et al. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. 2001;221:137-145.
6. Das T. Optimal therapeutic approaches to femoropopliteal artery intervention. Catheter Cardiovasc Interv. 2004;63:21-30.
7. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991;83:I70-I80.
8. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
9. van der Zaag ES, Legemate DA, et al. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg. 2004;28:132-137.
10. Zorger N, Manke C, Lenhart M. Peripheral arterial balloon angioplasty: effect of short versus long balloon inflation times on the morphologic results. J Vasc Interv Radiol. 2002;13:355-359.
11. Gray BH, Sullivan TM, Childs MB. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg. 1997;25:74-83.
12. Henry M, Henry I, Klonaris C, et al. Clinical experience with the OptiMed Sinus stent in the peripheral arteries. J Endovasc Ther. 2003;10:772-779.
13. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004;232:516-521.
14. Sabeti S, Mlekusch W, Amighi J, et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005;12:6-12.
15. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315.
16. Durand E, Mallat Z, Addad F, et al. Time course of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol. 2002;39:1680-1685.
17. Fava M, Loyola S, Polydorou A, et al. Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol. 2004;15:1239-1243.
18. Laird J, Jaff MR, Biamino G, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol. 2005;16:1067-1073.
19. Rabbi JF, Kiran RP, Gersten G, et al. Early results with infrainguinal cutting balloon angioplasty limits distal dissection. Ann Vasc Surg. 2004;18:640-643.
20. Ansel GM, Sample NS, Botti CF, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv. 2004;61:1-4.
21. Bolia A, Brennan J, Bell PR. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol. 1989;40:325.
22. Nydahl S, Hartshorne T, Bell PR, et al. Subintimal angioplasty of infrapopliteal occlusions in critically ischaemic limbs. Eur J Vasc Endovasc Surg. 1997;14:212-216.
23. Treiman GS, Whiting JH, Treiman RL, et al. Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation. J Vasc Surg. 2003;38:29-35.
24. Loftus IM, Hayes PD, Bell PR. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc Surg (Torino). 2004;45:217-229.
25. McCarthy RJ, Neary W, Roobottom C, et al. Short-term results of femoropopliteal subintimal angioplasty. Br J Surg. 2000;87:1361-1365.
26. Casserly IP, Sachar R, Bajzer C, et al. Utility of IVUS-guided transaccess catheter in the treatment of long chronic total occlusion of the superficial femoral artery. Catheter Cardiovasc Interv. 2004;62:237-243.
27. Saket RR, Razavi MK, Padidar A, et al. Novel intravascular ultrasound-guided method to create transintimal arterial communications: initial experience in peripheral occlusive disease and aortic dissection. J Endovasc Ther. 2004;11:274-280.
28. Zeller T, Rastan A, Schwarzwälder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther. 2004;11:676-685.
29. Wollenek G, Laufer G. Comparative study of different laser systems with special regard to angioplasty. Thorac Cardiovasc Surg. 1988;36(suppl 2):126-132.
30. Scheinert D, Laird JR, Schroder M, et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther. 2001;8:156-166.
31. Laird JR, Reiser C, Biamino G, et al. Excimer laser assisted angioplasty for the treatment of critical limb ischemia. J Cardiovasc Surg (Torino). 2004;45:239-248.
32. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg (Torino). 2004;45:193-201.
33. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000;217:95-104.
34. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311.
35. Deutschmann HA, Schedlbauer P, Berczi V, et al. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol. 2001;12:943-950.
36. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003;14:41-51.
37. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505-1509.
38. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338.
39. Heublein B, Rohde R, Kaese V, et al. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89:651-656.
40. Di Mario C, Griffiths H, Goktekin O, et al. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol. 2004;17:391-395.
41. Khalil AA. Catheter-based treatment of atherosclerosis. Options for effective percutaneous intervention are plentiful. Postgrad Med. 2004;115:14-6, 19-25.